|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/14 | |
| A61P 31/04 | |||
| A61P 17/00 |
| (11) | Number of the document | 2337575 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09810708.9 |
| Date of filing the European patent application | 2009-08-29 | |
| (97) | Date of publication of the European application | 2011-06-29 |
| (45) | Date of publication and mention of the grant of the patent | 2016-04-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/055466 |
| Date | 2009-08-29 |
| (87) | Number | WO 2010/025438 |
| Date | 2010-03-04 |
| (30) | Number | Date | Country code |
| 93314 P | 2008-08-30 | US | |
| 93497 P | 2008-09-02 | US |
| (72) |
LEHOUX, Dario, CA
PARR, Thomas R., US
MOECK, Gregory, CA
ETIENNE, Pierre, CA
|
| (73) |
The Medicines Company,
8 Sylvan Way, Parsippany, NJ 07054,
US
|
| (54) | METHODS OF TREATMENT USING SINGLE DOSES OF ORITAVANCIN |
| METHODS OF TREATMENT USING SINGLE DOSES OF ORITAVANCIN |